Research Topics
| N ZethraeusSummaryAffiliation: Stockholm School of Economics Country: Sweden Publications
|
Detail Information
Publications
Willingness to pay for hormone replacement therapyN Zethraeus
Stockholm School of Economics, Centre for Health Economics, Sweden
Health Econ 7:31-8. 1998..Finally, the implied WTP per gained quality adjusted life year (QALY) is estimated at about SEK 120000 and SEK 160000 based on the rating scale (RS) and time trade-off (TTO) methods, respectively...- Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women's Health Initiative randomized controlled trialNiklas Zethraeus
Centre for Health Economics, Stockholm School of Economics, PO Box 6501, SE 113 83 Stockholm, Sweden
Int J Technol Assess Health Care 21:433-41. 2005..Within a model framework using an individual state transition model, the cost-effectiveness of 50- to 60-year-old women with menopausal symptoms is assessed based on a societal perspective in Sweden... - Cost-effectiveness of the treatment and prevention of osteoporosis--a review of the literature and a reference modelN Zethraeus
Centre for Health Economics, Stockholm School of Economics, P O Box 6501, S 113 83 Stockholm, Sweden
Osteoporos Int 18:9-23. 2007.... - Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosisN Zethraeus
Centre for Health Economics, Stockholm School of Economics, Sweden
Osteoporos Int 13:841-57. 2002 - The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in SwedenN Zethraeus
Centre for Health Economics, Stockholm School of Economics, P O Box 6501, S 113 83 Stockholm, Sweden
Osteoporos Int 19:819-27. 2008..Cost-effective scenarios were found in all these chronic disorders. These findings are of relevance for decisions on the efficient allocation of health care resources... - A comparison of patient and social tariff values derived from the time trade-off methodN Zethraeus
Department of Economics, Stockholm School of Economics, Stockholm, Sweden
Health Econ 8:541-5. 1999..There was a close correspondence between social-tariff values and patient TTO values for relatively good health states, whereas the social tariff TTO values were lower than the patient TTO values for severe health states... - Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trialM Ekman
Department of Economics, Stockholm School of Economics, Sweden
Pharmacoeconomics 19:901-16. 2001..To investigate the cost effectiveness of adding the beta-blocker bisoprolol to standard treatment in patients with congestive heart failure (CHF)... - Nonparametric willingness-to-pay measures and confidence statementsM Tambour
Stockholm School of Economics, Sweden
Med Decis Making 18:330-6. 1998..The mean WTP was estimated for the full sample and separately for women with mild and severe menopausal symptoms. Using the proposed method, the mean WTP was significantly higher in the group with severe symptoms... - Bootstrap confidence intervals for cost-effectiveness ratios: some simulation resultsM Tambour
Centre for Health Economics, Stockholm School of Economics, Sweden
Health Econ 7:143-7. 1998..However, computing bootstrap confidence intervals directly for the CE ratio produce results closer to the predetermined significance level... - Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trialIngrid Lekander
i3 Innovus, Vasagatan 38, SE 111 20 Stockholm, Sweden
Bone 42:294-306. 2008..The purpose of the study was to assess the cost effectiveness of hormone therapy (HT) for postmenopausal women without menopausal symptoms at an increased risk of fracture in Sweden, the UK and the US... - Cost effectiveness of alendronate for the treatment of male osteoporosis in SwedenFredrik Borgstrom
Stockholm Health Economics, Sweden
Bone 34:1064-71. 2004..Similar effects of alendronate were observed in men in some other trials. There are also results demonstrating alendronate to be cost-effective in the treatment of osteoporosis in women... - [Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial]Linus Jönsson
Neurotec, Karolinska Institutet, Stockholm Health Economics, Centre for Health Economics, Stockholm School of Economics, Stockholm
Ugeskr Laeger 165:4112-6. 2003 - Predicting survival in cost-effectiveness analyses based on clinical trialsUlf G Gerdtham
Department of Community Medicine, , Sweden
Int J Technol Assess Health Care 19:507-12. 2003..Our main finding is that the results are sensitive to the choice of survival model and that an extensive sensitivity analysis in the CE analysis is required... - [Cost-effectiveness of bisoprolol in chronic heart failure]Mattias Ekman
Centrum för hälsoekonomi, Handelshögskolan i Stockholm
Lakartidningen 99:646-50. 2002.... 
Long-term cost and effect on quality of life of osteoporosis-related fractures in SwedenOskar Ström
Innovus, Stockholm, Sweden
Acta Orthop 79:269-80. 2008..This prospective observational data collection study assessed the cost and quality of life related to hip, vertebral, and wrist fracture 13-18 months after the fracture, based on 684 patients surviving 18 months after fracture...- [Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective]Fredrik Borgstrom
Centrum för hälsoekonomi, Handelshögskolan, Stockholm
Lakartidningen 100:36-40. 2003.... - Cost of lipid lowering in patients with coronary artery disease by case method learningAnna Kiessling
Karolinska Institute and Danderyd University Hospital, Sweden
Int J Technol Assess Health Care 21:180-6. 2005..This investigation was undertaken to study the costs of a Case Method Learning (CML)-supported lipid-lowering strategy in secondary prevention of coronary artery disease (CAD) in primary care... - Intervention thresholds for osteoporosis in the UKJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Sheffield, UK
Bone 36:22-32. 2005.... - Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studiesNiklas Zethraeus
Stockholm School of Economics, Centre for Health Economics, Stockholm, Sweden
Pharmacoeconomics 21:39-48. 2003..Based on these advantages the net-benefit approach should strongly be considered when analysing uncertainty in cost-effectiveness analyses... - Femoral neck fractures in the elderly: functional outcome and quality of life according to EuroQolJan Tidermark
Department of Orthopaedics, Karolinska Institute at Stockholm Söder Hospital, Sweden
Qual Life Res 11:473-81. 2002..Changes in the quality of life may be useful to identify patients who might benefit from reoperation, i.e. arthroplasty. The EQ-5D also appears to be a relevant clinical end-point in outcome studies... - Assessment of fracture riskJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Osteoporos Int 16:581-9. 2005..Treatment can then be offered to those identified to have a fracture probability greater than an intervention threshold... - Costs and quality of life associated with osteoporosis-related fractures in SwedenFredrik Borgstrom
Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
Osteoporos Int 17:637-50. 2006....